The General Party Branch of the Pharmaceutical Company Launches Education on the Theme of "Do not forget your initiative mind, Remember Mission"
Release time:
2020-07-22
General Party Branch of Pharmaceutical Company Launches "Do not forget your initiative mind, Remember Mission " Theme Education
News 7# November 27 , General Party Branch of Jinhua Pharmaceutical Company Organized All Party Members to Visit Chen Wangdao's Former Residence in Fenshuitang Village, Yiwu City to Carry out "to Visit Mr. Chen Wangdao, experience the Taste of Truth " "Do not forget your initiative mind, Remember Mission " Theme Education.
All Party members visited and studied Chen Wangdao's former residence, experienced the taste of truth and felt the power of faith. Under the leadership of General Branch Secretary Wu Weisheng, all Party members raised their right hands in the face of the Party flag wall, reviewed the oath of joining the Party, strengthened their initial belief in joining the Party, strengthened their lofty belief in "Do not forget your initiative mind, kept in mind the mission " , and further stimulated their political consciousness and mission to make contributions in the new era.
In the former residence of Chen Wangdao, the general party branch of the pharmaceutical company held a general meeting of all party members and held the third general election of the general party branch. In accordance with the procedures prescribed by the party constitution, all party members elected a new party branch committee through secret ballot and differential election, composed of three comrades Wu Weisheng, Fan Tufa, and Fu Senqiang. At the
meeting, Wu Weisheng, secretary of the general branch, reviewed the development history of the Communist Party of China and the arduous struggle process of leading the whole party and the whole army, and used his firm "to seek happiness for the people and the mission " to seek rejuvenation for the nation, how do Communist Party members in the new era give a special party lesson to all Party members in the aspects of "" keeping their first heart, undertaking their mission, finding gaps, and grasping the implementation of "in their posts. He asked all party members to combine their firm ideals and beliefs with practical work, truly play the vanguard and exemplary role of party members, and strive for new achievements.
Jin Huazhong, Secretary of the Party Committee of the Pharmaceutical Company, made a written speech. He said that it is of certain significance for the general branch of the pharmaceutical company to hold a general election in the patriotism education base. The administrative team united all party members and all employees and worked hard to express the achievements. He hopes that the new general party branch of the pharmaceutical company will continue to lead all party members and employees to keep their original aspirations in mind, keep their mission in mind, continue to strive for sustainability, continue to promote the spirit of the peak, and better play the role of the party organization as a battle fortress and the vanguard and exemplary role of party members. Make greater contributions to the reform and development of pharmaceutical companies. (Fan Tufa)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page